Back to search

University of Crete (UOC)

Μελέτη του βιολογικού ρόλου της ιστόνης Η1 και της κινάσης της συνθετάσης του γλυκογόνου (GSK-3) της Leishmania

Abstract

dc:description

Leishmania histone H1 (LeishH1) has been studied in the laboratory of molecular parasitology of the Hellenic Pasteur institute. Episomal expression of LeishH1 in L. major promastigotes results in overexpression of this molecule and reduces parasite infectivity in vitro and in vivo (Papageorgiou and Soteriadou, 2002; Smirlis et al., 2006). Interestingly, the reduced infectivity of the overexpressing transfectants was associated with a delay in their differentiation to axenic amastigotes, assessed in vitro (Smirlis et al., 2006). In the context of this study, we investigated whether the reduced infectivity and the delay in differentiation of the parasites over-expressing LeishH1 could be attributed to differences in their cell-cycle progression. The results suggest that over-expression of LeishH1 delays both the G1 to S transition and the progression through the S phase of the cell cycle. Similar results were obtained with L. infantum and L. major, which shows that LeishH1 upregulation results in a delay in cell cycle progression independently of the species studied. The results are in line with data on linker histones in metazoa, since their over-expression delays DNA synthesis and cell-cycle progression, which supports the idea that functional features of LeishH1 are conserved during evolution. Since LeishΗ1 levels of expression affect Leishmania cell cycle, we were also interested in molecules that can regulate LeishΗ1 function, especially through posttranslational modifications (e.g. phosphorylation). LeishΗ1 contains phosphorylation motifs by kinase/cyclin complexes, which might be involved in cell-cycle regulation (Papageorgiou and Soteriadou, 2002). In addition in T. cruzi two CDK homologues, TzCRK3 and TzCRK1 phosphorylate histone H1 in vitro (da Cunha et al., 2005). In Leishmania the two most wellstudied CDK homologues, CRK1 and CRK3, have not been shown to phosphorylate LeishΗ1. Consequently, the study of parasite kinases that possibly phosphorylate LeishΗ1 merits to be investigated. In this context, we studied the leishmanial glycogen synthase kinase-3 (GSK-3) homologue, as a molecule that might phosphorylate LeishΗ1. Recently, parasite kinases are considered promising drug targets and research is focused in the exploitation and expansion of chemical libraries of kinase inhibitors, which will selectively target parasite kinases without damaging the host (Hammarton et al., 2003; Naula et al., 2005). To this end, we identified and characterized one of the two GSK-3 forms in L. donovani, namely LdGSK-3short. LdGSK-3short is a highly conserved molecule in Leishmania species and displays 49% identity and 68% similarity with human GSK-3β. LdGSK-3short is expressed in both parasite stages and its expression pattern was comparable in logarithmic and stationary-phase promastigotes, but it was about 3-fold down-regulated in amastigotes, consistent with recent findings on LdGSK-3short expression in L. donovani axenic amastigotes (Rosenzweig et al., 2008). In addition, LdGSK-3short which had cytosolic and flagellar localization in logarithmic-phase promastigotes, displayed nuclear translocation in stationary-phase promastigotes. Of interest are also the findings that: a) LeishΗ1 is phosphorylated by LdGSK-3short in vitro and the phosphorylation is inhibited by 5-Me-6- BIO (as described below it was found to selectively inhibit LdGSK-3short) and b) LeishΗ1 is co-localized with LdGSK-3short in the nucleus of stationary-phase promastigotes. More data is needed in order to prove the in vivo interaction of LdGSK-3short with LeishH1. The investigation of the biological role of LdGSK-3short in the parasite was performed by the use of chemical inhibitors and genetic studies (overexpressing transfectants). The inhibitors used, indirubins are known inhibitors of mammalian GSK-3 and CDKs (Meijer et al., 2003) and were tested for their antileishmanial activity. Three 6-bromo substituted indirubins, 6-BIO, 6-BIA and 5-Me-6-BIO were powerful inhibitors of both L. donovani promastigote and amastigote growth (IC50 ? 1,2 μM). Promastigote treatment with 5-Me-6-BIO resulted in an accumulation of cells in S and G2/M phases of the cell-cycle and in the induction of apoptosis-like death. 6-BIO induced a dose- and time-dependent accumulation of cells in G2/M and the induction of apoptosis-like death in a lower proportion of promastigotes compared to 5-Me-6-BIO and this death process progressed more slowly. Since 6-bromo substitution on the indirubin backbone enhances the selectivity for mammalian GSK-3 over CDKs (Meijer et al., 2003) we investigated whether 5-Me-6-BIO and 6-BIO target LdGSK-3short and CRK3 (the CDK1 homologue) in vitro. Inhibitor screen assays against LdGSK-3short and CRK3 showed that 5-Me-6-BIO, which is a more potent inhibitor of mammalian GSK-3 over CDK1/Cyclin B displayed an approximately 7-fold selectivity for LdGSK-3short over CRK3. However, 6-BIO was about 7-fold more active towards CRK3 than LdGSK-3short, although it is a mammalian GSK-3 selective inhibitor. ...

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Xingi, Evangelia
  • Ξύγγη, Ευαγγελία

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24568

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Xingi, Evangelia; Ξύγγη, Ευαγγελία. Μελέτη του βιολογικού ρόλου της ιστόνης Η1 και της κινάσης της συνθετάσης του γλυκογόνου (GSK-3) της Leishmania. University of Crete (UOC), 2009. http://hdl.handle.net/10442/hedi/24568